ENDOPRIME NORGE AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−11k kr).
ENDOPRIME NORGE AS is registered as a limited company in Oslo, Oslo with organisation number 936236073. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2025. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Salg av medisinsk utstyr til helseforetak.”. The most recent filed accounts, for the 2025 financial year, show NOK 33,000 in revenue and NOK −11,000 in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns ENDOPRIME NORGE AS?
ENDOPRIME NORGE AS has 2 registered shareholders:
- MORTEN ANDERSEN 50.0%
- COMMANDER AS 50.0%
Frequently asked questions about ENDOPRIME NORGE AS
Who owns ENDOPRIME NORGE AS?
MORTEN ANDERSEN is the largest registered owner, with 50.0%.
What is the revenue of ENDOPRIME NORGE AS?
ENDOPRIME NORGE AS had revenue of NOK 33,000 in 2025.
Who is the general manager of ENDOPRIME NORGE AS?
Morten Andersen is registered as general manager of ENDOPRIME NORGE AS.
Where is ENDOPRIME NORGE AS based?
ENDOPRIME NORGE AS has its business address in Oslo.
Property
34 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.